Rehabilitation Research Group, Hospital del Mar Medical Research Institute (IMIM), Dr. Aiguader, 88, 08003 Barcelona, Catalonia, Spain.
PhD Program in Biomedicine, Department of Experimental and Health Sciences, Universitat Pompeu Fabra-Doctoral School, Dr. Aiguader, 88, 08003 Barcelona, Catalonia, Spain.
Nutrients. 2021 Feb 26;13(3):761. doi: 10.3390/nu13030761.
The recent publication of the revised Consensus on definition and diagnosis of sarcopenia (EWGSOP2) and the Global Leadership Initiative on Malnutrition (GLIM) criteria changed the approach to research on sarcopenia and malnutrition. Whilst sarcopenia is a nutrition-related disease, malnutrition and cachexia are nutritional disorders sharing the common feature of low fat-free mass. However, they have differential characteristics and etiologies, as well as specific therapeutic approaches. Applying the current definitions in clinical practice is still a challenge for health professionals and the potential for misdiagnosis is high. This is of special concern in the subgroup of older people with cancer, in which sarcopenia, malnutrition, and cancer cachexia are highly prevalent and can overlap or occur separately. The purpose of this review is to provide an updated overview of the latest research and consensus definitions of sarcopenia, malnutrition, and cachexia and to discuss their implications for clinical practice in older patients with cancer. The overall aim is to improve the quality of nutritional care in light of the latest findings.
最近发表的《肌少症定义和诊断的共识(EWGSOP2)》和《全球营养不良领导倡议(GLIM)标准》修订版改变了肌少症和营养不良研究的方法。虽然肌少症是一种与营养相关的疾病,但营养不良和恶病质是具有低去脂体重这一共同特征的营养障碍。然而,它们具有不同的特征和病因,以及特定的治疗方法。在临床实践中应用当前的定义仍然是对卫生专业人员的挑战,误诊的可能性很高。这在患有癌症的老年人亚组中尤为令人关注,其中肌少症、营养不良和癌性恶病质非常普遍,它们可能重叠或单独发生。本综述的目的是提供肌少症、营养不良和恶病质的最新研究和共识定义的最新概述,并讨论它们对癌症老年患者临床实践的影响。总体目标是根据最新发现提高营养护理的质量。